Vista Center Health Library
The Health Library at Vista Center is dedicated to providing accessible health information and resources to help people with vision loss understand their conditions and keep abreast of new treatments and research findings.
Resources ()
MSC-mediated mitochondrial transfer holds therapeutic promise for Leber’s hereditary optic neuropathy patients
Key Takeaways Mitochondria, often referred to as the powerhouses of the cell, help turn the energy we take from food into energy the cell can use. While most of the genetic material in a cell is contained the nucleus, mitochondria have their own set of genetic material, called mitochondrial DNA (mtDNA), that is important to their function. […]
Injectsense reports first human implantation of its IOP sensor
Key Takeaways Researchers successfully completed the first human implantation of a remote intraocular pressure (IOP) sensor manufactured by Injectsense, according to a press release from the company. The wireless IOP-Connect device was implanted in a minimally invasive, sutureless procedure. A team of researchers in Chile, who were led by Juan Mura, MD, of Centro de La Vision, […]
New gene therapy offers promise for treating glaucoma
Key Takeaways Scientists from Trinity College Dublin have developed a highly promising gene therapy to treat glaucoma. Their work, published in the International Journal of Molecular Genetics, shows that the gene therapy conferred significant benefit in animal models, and in human cells derived from people with glaucoma. Specifically, the therapy protected key “retinal ganglion cells” (RGCs) that […]
Gene therapy shows promise in glaucoma research
Key Takeaways In the 1980s, research into neurodegenerative diseases discovered a link between glaucoma and NAD, a type of molecule called a co-enzyme that binds to an enzyme and makes it active. Researchers showed that NAD levels were low in animal models of glaucoma. It was also found that when the body makes NAD, it […]
Tapping metabolomics for timely detection of glaucoma cases
Key Takeaways The number of individuals worldwide who are affected by glaucoma and who will be in the future is burgeoning. The current push is to identify biomarkers, biological molecules found in blood, other body fluids, or tissues that would enable earlier diagnosis, help determine those at higher risk of progression and provide new therapeutic […]
Impact of exercise on intraocular pressure in glaucoma patients
Key Takeaways Recent studies have reported that active and healthy living can reduce intraocular pressure (IOP), the pressure or force inside of your eyes. Since untreated high eye pressure can lead to glaucoma and harm your vision, many patients have consulted their doctors for lifestyle guidance based on this evidence. To increase the body of evidence regarding the […]
Field of vision data helping to track health outcomes
Key Takeaways Researchers at The University of Western Australia have designed a new method to extract data on a large scale to assess and track changes in people’s field of vision. In a study published in Clinical & Experimental Ophthalmology, researchers collected data from more than 600,000 visual field tests from 92,000 individuals who attended an […]
New data for port delivery system demonstrates sustained efficacy for two serious diabetic eye diseases
Key Takeaways Two-year Phase III data presented at the 2024 American Society of Retina Specialists annual meeting show Genentech’s Susvimo™ port delivery system’s potential as an alternative to eye injections to treat diabetic macular edema (DME) and diabetic retinopathy (DR). The results build on the primary one-year analyses of the Phase III Pagoda and Pavilion […]
Therapeutic in development to take on diabetic macular edema
Key Takeaways With 37 million people in the United States impacted by diabetes, and cases of diabetic macular edema (DME) on the rise, pipelines are primed for the development of new treatment options to combat the disease. DME results from buildup of fluid in the macula from leaky blood vessel walls. (The macula is a small but important area in […]
GLP-1 agonists may offer protection against glaucoma in type 2 diabetes
Key Takeaways Diabetic patients treated with GLP-1 receptor agonists (GLP-1RAs) had a 41-50% lower relative risk of developing the most common form of glaucoma (primary open-angle glaucoma, or POAG) as compared with metformin, a large retrospective study showed. A similar protective advantage for GLP-1RAs versus metformin was evident for ocular hypertension, having higher than normal pressure […]
Disclaimer: Reports are excerpted/edited unless otherwise noted. Medical definitions are provided via Google/medical dictionaries. This project is done as a courtesy to the blind and visually impaired community. We do not recommend any particular treatment. Our Material might not represent all that is available on the subject. This information might not apply specifically to your own condition. Our material is not intended as a substitute for medical care. Our material should be used to formulate questions for discussion with your physician. We hope that the information you find at The Health Library will be useful in communicating with your health professionals. If you have any questions about your unique medical condition, we strongly advise that you see your physician.
We would like to give a special tribute of thanks to Miriam Kaplan, PhD, Editor-in-Chief and Coordinator, and Dawn Wilcox, BSN, RN, Associate Editor who have worked with dedication to provide reliable, up-to-date health information to support individuals with vision loss, their families, and the broader community.